Back to UBS Group AG UBS Group AG

PCRXPCRX
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in PACIRA BIOSCIENCES INC

UBS Group AG holds 920,217 shares of PCRX (PACIRA BIOSCIENCES INC), worth $23.3M as of 2026-Q2. The position was increased (+63.7% shares). PCRX represents 0.0% of UBS Group AG's portfolio.

Current Value

$23.3M

Current Shares

920,217

Total Value Change

+$20.5M

Total Shares Change

+729,462

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
920,217
+63.7%
$23.3M0.0%$25.37
42
2026-Q1
Increased
562,040
+0.6%
$12.7M0.0%$22.60
28
2025-Q4
Decreased
558,651
-34.6%
$14.5M0.0%$25.88
0
2025-Q3
Decreased
854,861
-16.9%
$22M0.0%$25.77
0
2025-Q2
Increased
1M
+143.9%
$24.6M0.0%$23.90
46
2025-Q1
Decreased
421,832
-69.3%
$10.5M0.0%$24.85
0
2024-Q4
Increased
1.4M
+620.7%
$25.9M0.0%$18.84
46
2024-Q3
Increased
190,755
+190.5%
$2.9M0.0%$15.05
42

Other major holders of PCRX: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used